These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1535157)

  • 21. Oncogenic forms of p53 inhibit p53-regulated gene expression.
    Kern SE; Pietenpol JA; Thiagalingam S; Seymour A; Kinzler KW; Vogelstein B
    Science; 1992 May; 256(5058):827-30. PubMed ID: 1589764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The bradykinin type 2 receptor is a target for p53-mediated transcriptional activation.
    Saifudeen Z; Du H; Dipp S; El-Dahr SS
    J Biol Chem; 2000 May; 275(20):15557-62. PubMed ID: 10748162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human T-cell lymphotropic virus type I (HTLV-I) transcriptional activator, Tax, enhances CREB binding to HTLV-I 21-base-pair repeats by protein-protein interaction.
    Zhao LJ; Giam CZ
    Proc Natl Acad Sci U S A; 1992 Aug; 89(15):7070-4. PubMed ID: 1386673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A trans-activator Tax of human T-cell leukemia virus type 1 binds to NF-kappa B p50 and serum response factor (SRF) and associates with enhancer DNAs of the NF-kappa B site and CArG box.
    Suzuki T; Hirai H; Fujisawa J; Fujita T; Yoshida M
    Oncogene; 1993 Sep; 8(9):2391-7. PubMed ID: 8361755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Functional heterogeneity of p53-responsive elements].
    Kondratov RV; Kuznetsov NV; Pugacheva EN; Almazov VP; Prasolov VS; Kopnin BP; Chumakov PM
    Mol Biol (Mosk); 1996; 30(3):613-20. PubMed ID: 8754008
    [No Abstract]   [Full Text] [Related]  

  • 26. Two functionally divergent p53-responsive elements in the rat bradykinin B2 receptor promoter.
    Marks J; Saifudeen Z; Dipp S; El-Dahr SS
    J Biol Chem; 2003 Sep; 278(36):34158-66. PubMed ID: 12791684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A cAMP-responsive element binding site is essential for sterol regulation of the human lanosterol 14alpha-demethylase gene (CYP51).
    Halder SK; Fink M; Waterman MR; Rozman D
    Mol Endocrinol; 2002 Aug; 16(8):1853-63. PubMed ID: 12145339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergism between two distinct elements of the HTLV-I enhancer during activation by the trans-activator of HTLV-I.
    Numata N; Ohtani K; Niki M; Nakamura M; Sugamura K
    New Biol; 1991 Sep; 3(9):896-906. PubMed ID: 1931834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of the human T-cell lymphotrophic virus type I (HTLV-I) transcriptional activator Tax with cellular factors that bind specifically to the 21-base-pair repeats in the HTLV-I enhancer.
    Zhao LJ; Giam CZ
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11445-9. PubMed ID: 1763059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repression of the human glycoprotein hormone alpha-subunit gene by glucocorticoids: evidence for receptor interactions with limiting transcriptional activators.
    Chatterjee VK; Madison LD; Mayo S; Jameson JL
    Mol Endocrinol; 1991 Jan; 5(1):100-10. PubMed ID: 1708098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of Tax and PKA-mediated expression of HTLV-I promoter via cAMP response element binding and modulator proteins CREB and CREM.
    Bodor J; Walker W; Flemington E; Spetz AL; Habener JF
    FEBS Lett; 1995 Dec; 377(3):413-8. PubMed ID: 8549766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of the human IgE receptor (Fc epsilon RII/CD23) by EBV. Localization of an intron EBV-responsive enhancer and characterization of its cognate GC-box binding factors.
    Lacy J; Roth G; Shieh B
    J Immunol; 1994 Dec; 153(12):5537-48. PubMed ID: 7989755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of DNA repair by human T cell leukemia virus type 1 Tax is rescued by a functional p53 signaling pathway.
    Kao SY; Lemoine FJ; Marriott SJ
    J Biol Chem; 2000 Nov; 275(46):35926-31. PubMed ID: 10931836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wild-type human p53 transactivates the human proliferating cell nuclear antigen promoter.
    Shivakumar CV; Brown DR; Deb S; Deb SP
    Mol Cell Biol; 1995 Dec; 15(12):6785-93. PubMed ID: 8524244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a negative element in the human vimentin promoter: modulation by the human T-cell leukemia virus type I Tax protein.
    Salvetti A; Lilienbaum A; Li Z; Paulin D; Gazzolo L
    Mol Cell Biol; 1993 Jan; 13(1):89-97. PubMed ID: 8417364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Further characterisation of the p53 responsive element--identification of new candidate genes for trans-activation by p53.
    Bourdon JC; Deguin-Chambon V; Lelong JC; Dessen P; May P; Debuire B; May E
    Oncogene; 1997 Jan; 14(1):85-94. PubMed ID: 9010235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stimulation of polyomavirus DNA replication by wild-type p53 through the DNA-binding site.
    Kanda T; Segawa K; Ohuchi N; Mori S; Ito Y
    Mol Cell Biol; 1994 Apr; 14(4):2651-63. PubMed ID: 8139565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of viral and cellular promoters by human wild-type p53.
    Subler MA; Martin DW; Deb S
    J Virol; 1992 Aug; 66(8):4757-62. PubMed ID: 1352831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell line-dependent response of the enhancer element of simian virus 40 to transactivator p40tax encoded by human T-cell leukemia virus type I.
    Nakamura M; Niki M; Nagata K; Ohtani K; Saito S; Hinuma Y; Sugamura K
    J Biol Chem; 1989 Dec; 264(34):20189-92. PubMed ID: 2555345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural determinants for transcriptional activation by cAMP-responsive DNA elements.
    Deutsch PJ; Hoeffler JP; Jameson JL; Lin JC; Habener JF
    J Biol Chem; 1988 Dec; 263(34):18466-72. PubMed ID: 2848037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.